The “Right to Try” Psilocybin and New Drug Therapies
Canna Law Blog
NOVEMBER 10, 2020
Unlike with many precursor state laws, no institutional review board review is required. The question for doctors and patients will be whether these drugs are worth a look in each case scenario, and beyond that, whether dealing with Right to Try or one of the state law analogues is worth it.
Let's personalize your content